The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic procedures to provide lift and contrast during resection of lesions in the gastrointestinal tract, according to a news release shared with Becker’s. It uses sodium hyaluronate for lift, methylene blue for contrast, and is supplied in a prefilled syringe.
Blue Eye additionally has double the long-lasting mucosal elevation, according to its website, reducing procedure times.
The injection also uses hyaluronic acid, a biopolymer in human dermis, making it biocompatible.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
